Evidence map›Paper›PMID 41712592›Full record

ArticlePloS one2026

Application of NMRK immobilized enzymes in the synthesis of NMN.

Shan Yang, Ting Xiang, Jinchun Qian, Wei Sun, Wenjun Liu, Nengwen Yi, Zheng-Hong Qin

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shan YangMedical Department, Suzhou Gao Bo Vocational College, Suzhou, China.ORCID https://orcid.org/0009-0003-7360-5545
Ting XiangDepartment of Pharmaceutical Management, Suzhou Gao Bo Vocational College, Suzhou, China.
Jinchun QianInstitute of Health Science and Technology, Suzhou Gao Bo Vocational College, Suzhou, China.
Wei SunSuzhou Ren Ben Pharmaceutical Co., Ltd., Suzhou, China.
Wenjun LiuInstitute of Health Science and Technology, Suzhou Gao Bo Vocational College, Suzhou, China.
Nengwen YiSuzhou Ren Ben Pharmaceutical Co., Ltd., Suzhou, China.
Zheng-Hong QinInstitute of Health Science and Technology, Suzhou Gao Bo Vocational College, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the study is to provide a method for mass production of nicotinamide mononucleotide (NMN) using an immobilized nicotinamide riboside kinase (NMRK). We synthesized a gene sequence comprising the gene encoding the enzyme. At the 3' end of this NMRK-encoding gene, an optimized cellulose-binding domain (CBD) sequence was linked via a linker-encoding gene segment.Using the pET-32a plasmid as the vector and Escherichia coli BL21(DE3) as the host cell, the recombinant E. coli strain BL21/pET-32a-nmrk-1 was constructed and cultivated. This recombinant strain BL21/pET-32a-nmrk-1 secreted a significantly higher yield of the NMRK enzyme protein (32 mg/mL), and the secreted recombinant NMRK enzyme exhibited superior activity (80 U/g). Activated microcrystalline cellulose was mixed with the crude enzyme solution containing the recombinant NMRK enzyme. Following processing, the immobilized NMRK enzyme was obtained. This immobilized enzyme catalyzed the synthesis of NMN from 0.07 mol/L nicotinamide riboside (NR), achieving a conversion rate of 90% and a purity of 33%. The recombinant NMRK enzyme retained good activity after immobilization onto the carrier, enabling its reuse for more than 10 cycles. The initial activity of the immobilized NMRK enzyme was 540 U/g. After 11 cycles of use, the activity was 390 U/g, representing only a 27.8% decline in activity. This approach enhances the utilization efficiency of the NMRK enzyme while simultaneously reducing the production cost of NMN.

Indexed as

Enzymes, ImmobilizedNicotinamide MononucleotidePhosphotransferases (Alcohol Group Acceptor)Escherichia coliRecombinant ProteinsEnzymes, ImmobilizedNicotinamide MononucleotidePhosphotransferases (Alcohol Group Acceptor)Recombinant Proteins

Identifiers

PMID41712592
PMCPMC12919835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.